SCHEMBL4030624

SCHEMBL4030624

CN1CCc2c([nH]c3c(NS(=O)(=O)c4ccc5ccccc5c4)cccc23)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAD52 P43351 1/20 0.46
HTR7 P34969 5/20 0.45
HTR6 P50406 4/20 0.45
HTR1A P08908 3/20 0.45
HTR2C P28335 3/20 0.45
HTR2A P28223 1/20 0.45
DRD3 P35462 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
GLO1 Q04760 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PLAU P00749 1/20 0.42
LMNA P02545 2/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
GHSR Q92847 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12316154 0.89 HTR6 (0.46) HTR7HTR6HTR1AHTR2CHTR2A
SCHEMBL4023382 0.86 KDM4E (0.48) HTR7HTR6HTR2CHTR2AKDM4E
SCHEMBL3887695 0.82 CCR2 (0.44) KDM4E
SCHEMBL4022862 0.80 HTR6 (0.59) HTR7HTR6HTR1AHTR2CHTR2A
SCHEMBL3880376 0.80 KDM4E (0.45) HTR7HTR6HTR1AHTR2CHTR2A
Hydrochloric Acid SCHEMBL4031202 0.80 HTR6 (0.60) HTR7HTR6HTR1AHTR2CHTR2A
SCHEMBL10239554 0.78 HTR7 (0.54) RAD52HTR7HTR6HTR1AHTR2C
SCHEMBL12316152 0.78 HTR6 (0.45) HTR6KDM4EMEN1KMT2ATDP1
Hydrochloric Acid SCHEMBL9960408 0.77 RAD52 (0.55) RAD52HTR7HTR6HTR1AHTR2C
SCHEMBL4019412 0.77 EDNRA (0.46) HTR6KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919475-B1 TETRAHYDRO- BETA-CARBOLIN-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS ESTEVE LABOR DR (ES) 2009-03-11 EP claimed
US-8263609-B2 Tetrahydro-β-carbolin-sulfonamide derivatives as 5-Ht6 ligands LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-09-11 US disclosed
US-8263609-B2 Tetrahydro-β-carbolin-sulfonamide derivatives as 5-Ht6 ligands LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2012-09-11 US disclosed
EP-1919475-B1 TETRAHYDRO- BETA-CARBOLIN-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS ESTEVE LABOR DR (ES) 2009-03-11 EP disclosed
US-20080280942-A1 Tetrahydro-Beta-Carbolin-Sulfonamide Derivatives as 5-Ht6 Ligands LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2008-11-13 US disclosed
US-20080280942-A1 Tetrahydro-Beta-Carbolin-Sulfonamide Derivatives as 5-Ht6 Ligands LABORATORIES DEL DR. ESTEVE, S.A. (ES) 2008-11-13 US disclosed
WO-2007028460-A1 TETRAHYDRO-β-CARBOLIN-SULFONAMIDE DERIVATIVES AS 5-HT6 LIGANDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280942-A1 Tetrahydro-Beta-Carbolin-Sulfonamide Derivatives as 5-Ht6 Ligands HTR6, HTR5A, HTR1B RAD52 3646/4885HTR7 11/4885HTR6 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.